1. Carpal Tunnel Syndrome Due to Iatrogenic Amyloidosis After Domino Liver Transplantation From Hereditary Transthyretin Amyloidosis: A Case Report
- Author
-
Kazumi Kuriwaki, Toru Tsuchida, Yukihiro Inomata, Masayoshi Tasaki, Nobuhiro Katayama, Mitsuharu Ueda, Yuki Ohya, and Shintaro Hayashida
- Subjects
Pathology ,medicine.medical_specialty ,Amyloid ,medicine.medical_treatment ,Liver transplantation ,Renal Dialysis ,medicine ,Humans ,Prealbumin ,Renal Insufficiency, Chronic ,Carpal tunnel syndrome ,Amyloid Neuropathies, Familial ,Transplantation ,Carpal Joints ,biology ,business.industry ,Amyloidosis ,Middle Aged ,medicine.disease ,Carpal Tunnel Syndrome ,Tissue Donors ,Liver Transplantation ,nervous system diseases ,Transthyretin ,Amyloid Neuropathy ,biology.protein ,Female ,Surgery ,Portosystemic shunt ,business ,Kidney disease - Abstract
Background Carpal tunnel syndrome is the most common compression syndrome of the peripheral nerve. Transthyretin amyloidosis and dialysis-related β2-microglobulin amyloidosis are known causes of carpal tunnel syndrome. Case Report A Japanese woman showed carpal tunnel syndrome 16 years after a domino liver transplantation (DLT) from the donor with hereditary transthyretin amyloidosis. DLT indication was congenital extrahepatic portosystemic shunt, and the patient had been put on maintenance hemodialysis because of chronic kidney disease 6 years before DLT. Moreover, the amyloid precursor protein of the patient was histologically confirmed not to be β2-microglobulin, but transthyretin. Conclusions The existence of amyloid was speculated when the patient who underwent DLT from hereditary transthyretin amyloidosis showed carpal tunnel syndrome. Additionally, elucidating the amyloid precursor protein when the patient has another cause of amyloidosis is necessary.
- Published
- 2021